Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

195.45 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about AbbVie

< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
61 62 Next >
7 Mega-Cap Stocks to Buy for the Long Haul
If you’re looking for a stock you can buy and hold for a long time, then these mega-cap stocks to by fit the bill. 
Via InvestorPlace
Recent Stock Purchase/Sale February 2023
I have been busy buying up some stock this month and was happy to put some fresh and recycled capital to work to try and recoup some of my lost dividend income courtesy of the numerous cuts bestowed... 
Via Talk Markets
3 Stocks to Buy Right Now That Are Cash Cows
If cash is king, these three stocks should wear crowns. 
Via The Motley Fool
The Ultimate Inflation Hedge: Dividends
Whatever the inflation rate that unfolds during the next 10-30 years, your annual expenses will be going up each year. In such an environment, a bond and cash portfolio will not see you through... 
Via Talk Markets
Infinity Pharmaceuticals Announce Merger Agreement With MEI Pharma, Share Plunge
Via Benzinga
Where AbbVie Stands With Analysts
Via Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have $400 Today
Via Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Healthcare Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
7 Dividend Yield Monsters Poised to Soar
These high-yield dividend stocks are poised to soar as investors pile onto growing companies offering regular income. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
Via Benzinga
Want to Get to $1 Million by Retirement? Here's How Much You Should Invest Today.
If you want to be a millionaire more quickly, you can always invest more along the way. 
Via The Motley Fool
Want More Reliable Dividend Income? Buy This Dividend King.
This big pharma company possesses a deep drug portfolio and pipeline. 
Via The Motley Fool
This Recession-Proof Company Has a Best-in-Class Dividend
Pfizer's highly attractive valuation, rock-solid dividend program, and enormous yield put it at the top of its big pharma peer group. 
Via The Motley Fool
3 Top Dividend Kings to Buy for the Long Haul
These companies have more than 150 years of dividend growth between them. 
Via The Motley Fool
3 Dividend Stocks That Should Pay You the Rest of Your Life
Each of these companies can provide income investors with growing, market-beating passive income. 
Via The Motley Fool
3 Stocks At An Inflection Point
With consumer and producer prices surprising to the upside, multiple research outlets are starting to call for more aggressive Fed ... 
Via Benzinga
2 Exceptional Growth Stocks to Buy Before the Next Bull Market
Both of these companies have long runways for growth and catalysts on the way. 
Via The Motley Fool
3 Exceptional Dividend Stocks to Buy Right Now
These stocks can add to your returns -- no matter what the stock itself or the general market is doing. 
Via The Motley Fool
These 2 Growth Stocks Are Easily Defying the Bear Market
Impressively, neither company is predicting rapid growth. 
Via The Motley Fool
Is This the Start of a Nightmare for AbbVie Stock?
With a competitor set to devour market share, stormy waters might be ahead. 
Via The Motley Fool
3 Defensive Growth Stocks to Load Up on in Q1
These three defensive growth stocks are excellent options to consider for investors concerned about continued volatility in Q1. 
Via InvestorPlace
2 High-Yielding Dividend Stocks Trading Near 52-Week Lows
These stocks both yield more than 3% right now. 
Via The Motley Fool
3 of the BEST Dividend Growth Stocks
All three of these companies have consistently increased their dividends at a fast pace. 
Via The Motley Fool
Better Buy: Johnson & Johnson or AbbVie?
The healthcare giants are favored by income-oriented investors but have a potentially disruptive year ahead. 
Via The Motley Fool
Tuesday Talk: My Sweet CPI
The street is hoping for sweet January CPI data today and that anticipation pushed stocks higher on Monday. 
Via Talk Markets
The 7 Most Undervalued Dividend Aristocrats to Buy
With so many uncertainties ahead, investors may take comfort in the stability of the most undervalued dividend aristocrats to buy. 
Via InvestorPlace
Large-Cap Biopharmaceuticals: Bearish Sentiment Curbs Buyers
Large cap biopharma stocks are off their highs despite reasonable valuations plus dividends. 
Via Talk Markets
GlycoMimetics Audio Discussion And Analysis With Dan Cohen And Scott Matusow
Dan Cohen and Scott Matusow discuss In this 1:11 audio the upcoming data sets for Glycomimetics. We talk about The Company's platform chemistry in depth, and give our predictions for success/failure of... 
Via Talk Markets
Here's Exactly How AbbVie Stock Can Beat the Market In 2023
Don't think the challenges for Humira doom AbbVie to a sub-par stock performance this year. 
Via The Motley Fool
AbbVie's Humira: The Downfall Won't Be As 'Draconian' As Initially Expected
The company expects Humira sales to fall 37% this year. 
Via Investor's Business Daily
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
61 62 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.